View Clinical Trial (Medical Research Study)

A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Dose-Range Study of DER 45 EV Gel, 1% and 5%, and Vehicle Gel in the Treatment of Rosacea

This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials

---

Conditions:		Rosacea
Purpose:		To identify lowest efficacious dose of DER 45 EV Gel, 1% and 5% verses vehicle in patients with rosacea.
Study Summary:
Criteria:		Inclusion Criteria: - Males and females, 18 years of age or older - Facial rosacea, with 12 or more inflammatory lesions (with no more than 2 nodules) - Mild, Moderate or Severe (2, 3 or 4) rating of rosacea on the IGA - Females of child-bearing potential must have negative urine pregnancy test result at baseline and must be willing to use an effective form of contraception throughout the study Exclusion Criteria: - Subjects who are pregnant, breast feeding, or planning a pregnancy during the study - Allergy or sensitivity to ingredients in test product - Any dermatological conditions of the face that may interfere with study evaluations - Subjects unable to avoid or minimize exposure to factors that may exacerbate or trigger rosacea
NCT ID:		NCT00940992
Primary Contact:		Study Director Ofra Levy-Hacham, PhD Sponsor GmbH
Backup Contact:		N/A
Location Contact:		Spokane, Washington 99204 United States There is no listed contact information for this specific location. Site Status: N/A

---

---